Stock research

MRNA Moderna, Inc.

Healthcare • Biotechnology

$54.82
-3.10 (—%)

Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts...…

1Y change

+98.34%

Range high

$81.80

Congress · 90d

0

Insiders · 90d

0

Public signal layer

Who is disclosing activity in MRNA?

Latest linked filings in Indy

Congress

View all
RK Ro Khanna $1,001 - $15,000 SALE Jan. 29, 2026
RK Ro Khanna $1,001 - $15,000 SALE Aug. 26, 2025
RK Ro Khanna $1,001 - $15,000 PURCHASE Jul. 25, 2025
RB Robert P. Bresnahan $1,001 - $15,000 SALE (FULL) Apr. 8, 2025

Corporate insiders

View all

No insider transactions yet.

Price

Hover to inspect price

Showing 1Y history. Source: FMP historical price full.

Prev Close
$57.92
Day High
$59.49
Day Low
$54.74
52w High
$85.60
52w Low
$22.28
Volume
7,754,754
Avg Volume
Beta
0.942

* TTM/most recent where available

Company

Ticker
MRNA
Exchange
Sector
Healthcare
Industry
Biotechnology
Country
US
CEO
Stéphane Bancel
Employees
4700
Website
www.modernatx.com

Key Metrics

Market Cap
21.8B
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available

DCF Valuation

↓ Below DCF -3319.7%

Standard DCF

-$1.70 as of Aug. 2, 2026

Levered DCF

-$3.44 as of Aug. 2, 2026

Market Price

$54.82 vs DCF -3319.7%

DCF vs Price (30D window)

Price uses last 30 days; DCF line holds latest value across the window.

DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).